Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIMIT
NCT03636295Phase 3Recruiting
- Sponsor
- Population Health Research Institute
- Start
- Sep 2019
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 18
01
Overview
Phase 3, randomised trial of warfarin in thromboembolism (2 arms), sponsored by Population Health Research Institute. Primary endpoints: Thrombosis/thromboembolism and Major bleeding. Started Sep 2019; status: recruiting.
02
Drugs
warfarin
03
Conditions
thromboembolism
Beyond the preview
Go deeper on NCT03636295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03636295.